BRÈVE publiée le 07/01/2025 à 13:05, il y a 10 mois 28 jours GEON Performance Solutions Acquires Foster Corporation Acquisition Healthcare Industry GEON Performance Solutions Foster Corporation Medical Polymers
BRÈVE publiée le 07/01/2025 à 13:05, il y a 10 mois 28 jours GEON Performance Solutions acquiert Foster Corporation Acquisition Secteur De La Santé Solutions De Performance GEON Société Foster Polymères Médicaux
COMMUNIQUÉ DE PRESSE publié le 07/01/2025 à 13:00, il y a 10 mois 28 jours GEON Performance Solutions Acquires Foster Corporation GEON Performance Solutions acquires Foster Corporation, expanding medical polymer solutions. Strategic move to enhance high-value medical market participation Acquisition GEON Performance Solutions Foster Corporation Medical Polymer Solutions High-value Healthcare Market
BRÈVE publiée le 11/03/2024 à 16:05, il y a 1 année 8 mois GEON(R) Mexico Announces $1.3 Million Expansion GEON Performance Solutions Manufacturing Expansion Polymer Solutions Ramos Arizpe Facility Technology Centers Of Excellence
BRÈVE publiée le 11/03/2024 à 16:05, il y a 1 année 8 mois GEON(R) Mexique annonce une expansion de 1,3 million de dollars Expansion De La Fabrication Solutions De Performances GEON Solutions Polymères Installation De Ramos Arizpe Centres D'excellence Technologiques
COMMUNIQUÉ DE PRESSE publié le 11/03/2024 à 16:00, il y a 1 année 8 mois GEON(R) Mexico Announces $1.3 Million Expansion GEON Performance Solutions announces a $1.3 million expansion at Ramos Arizpe, Mexico facility to enhance polyolefin compound manufacturing, post Polymax acquisition Expansion GEON Performance Solutions Ramos Arizpe Polyolefin Compound Manufacturing Polymax Acquisition
COMMUNIQUÉ DE PRESSE publié le 01/12/2023 à 18:15, il y a 2 années GEON(R) Performance Solutions Acquires PolymaxTPE GEON Performance Solutions, a global leader in performance polymer solutions, acquires PolymaxTPE, a leader in TPE materials. This strategic acquisition allows GEON to expand its market reach and leverage PolymaxTPE's expertise Acquisition Global Leader GEON Performance Solutions PolymaxTPE TPE Materials
Publié le 04/12/2025 à 18:14, il y a 13 heures 35 minutes Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 50 minutes Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 50 minutes Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 14 heures 5 minutes Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 14 heures 5 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 05/12/2025 à 02:35, il y a 5 heures 15 minutes Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 01:00, il y a 6 heures 50 minutes BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 45 minutes BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 50 minutes NXT Energy Solutions Completes Data Acquisition for SFD Survey
Publié le 05/12/2025 à 07:00, il y a 49 minutes Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 4 heures 19 minutes CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 7 heures 59 minutes EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 11 heures 24 minutes Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 11 heures 35 minutes Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
